Mirum gets FDA approval for rare bone disorder drug
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Health & Medicine
FDA approves Mirum’s drug for ultra-rare soft tissue disease
The FDA has approved the third treatment for a debilitating genetic disease that turns muscle and connective tissue to bone.
H5N1 could be high-risk pandemic source — Imperial expert
The highly pathogenic H5N1 avian influenza virus could pose a high risk as a source of a future pandemic, as its spread across birds and mammals continues to expand, a leading infectious disease…
Province hires 17 psychiatrists to work in Winnipeg, Selkirk
The province has hired 17 psychiatrists this year in an attempt to alleviate pressure on hospital emergency rooms. “Too often, people in crisis end up in the emergency room because […]
- Province hires 17 psychiatrists in Manitoba to ease ER burden
- 14 psychiatrists based in Winnipeg, 3 at Selkirk Mental Health Centre
- Psychiatrists have diverse expertise in child, adolescent, and geriatric care
How online toxicity silences the majority and fuels power users
A recent field experiment on Reddit reveals why a vocal minority dominates online political discussions, finding that toxic environments silence the majority while fueling the most active users.
DOL provides guidance to employers on responding to opioid overdoses
The guidance is part of the Great American Recovery Initiative, an effort by the Trump Administration focused on addiction treatment and recovery.
How unarmed 911 teams are reshaping public safety in nearly 100 cities
Programs that send mental health workers out to 911 calls instead of police have grown in recent years. But doing them right is a challenge.